Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study

BACKGROUND: Prior studies regarding use of Aromatase inhibitors (AIs) and risk for cardiovascular disease (CVD) have shown conflicting results. This retrospective cohort study aimed to investigate whether AIs use affects risk for CVD events in postmenopausal breast cancer survivors. METHODS: Using a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast
Главные авторы: Sund, Maria, Garcia-Argibay, Miguel, Garmo, Hans, Ahlgren, Johan, Wennstig, Anna-Karin, Fredriksson, Irma, Lindman, Henrik, Valachis, Antonis
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8281646/
https://ncbi.nlm.nih.gov/pubmed/34265496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.07.004
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы